Gene mutations in acute myeloid leukemia (AML) cells can guide treatment options, and machine learning can rapidly guess the existence of gene mutations based on images of leukemia cells.
News Medical on MSN12d
New Treatment Strategy Increases Cell Death in LeukemiaScientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that ...
In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...
Acute myeloid leukemia (AML) is one of the most aggressive and genetically complex cancers, marked by the unchecked growth of ...
Clinical Trials Arena on MSN1d
Cantargia enrols first patient in trial of nadunolimab for AML and MDSSwedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals ...
The combined use of two well-known active substances can fight leukemic cells and limit their spread. This is the result of a ...
Anthony Stein, MD, assessed total marrow and lymphoid irradiation with post-transplant cyclophosphamide in patients with ...
Researchers from Karl Landsteiner University of Health Sciences (KL Krems) have discovered that combining two existing drugs ...
Actimab-A is a humanized anti-CD33 antibody conjugated to Actinium-225 (Ac-225). With its potent alpha-particle payload ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback